FDA permits marketing of device to treat diabetic foot ulcers
FDA.gov Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. “Diabetes is the leading cause of lower limb amputations,” said Binita Ashar, M.D ... |
December 28, 2017 at 05:06PM | marketing - Google News
FDA permits marketing of device to treat diabetic foot ulcers - FDA.gov
marketing - Google News
Nenhum comentário:
Postar um comentário